학술논문
Second dose of COVID‐19 vaccination in immediate reactions to the first BNT162b2.
Document Type
Article
Source
Subject
*COVID-19 vaccines
*URTICARIA
*COVID-19
*MESSENGER RNA
*VACCINATION complications
*ALLERGIES
*
*
*
*
*
Language
ISSN
0905-6157
Abstract
Keywords: allergy; BNT162b2; children; COVID-19; hypersensitivity; pediatric; vaccine EN allergy BNT162b2 children COVID-19 hypersensitivity pediatric vaccine 1 5 5 01/05/22 20220101 NES 220101 Abbreviations BAT basophil activation test COVID-19 coronavirus disease 2019 mRNA messenger ribonucleic acid ACKNOWLEDGEMENTS This work was supported by the research grant COVID19F02 from the Food and Health Bureau of the Government of Hong Kong. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy. Allergy, BNT162b2, children, COVID-19, hypersensitivity, pediatric, vaccine. [Extracted from the article]